header
Image from OpenLibrary

The prevalence of BRAF gene mutations among Egyptian patients with Papillary Thyroid Carcinoma / Sara Mohamed Tawfic Elkhateeb ; Supervised Ahmed Eltaweel , Sherif Elrafaei , Dina Ahmed Mehaney

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Sara Mohamed Tawfic Elkhateeb , 2013Description: 92 P. : charts , facsimiles ; 25cmOther title:
  • شيوع طفرة البى راف فى المرضى المصريين المصابين بسرطان الغدة الدرقية الحليمى [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology Summary: Background: The activating point mutation v-Raf murine sarcoma viral oncogene homology B1 (BRAFV600E), is the most common and specific genetic alteration in papillary thyroid carcinoma (PTC) with a prevalence of 29-83% the mutation causes a change in amino acid at position 600 from valine to glutamic acid in the BRAF protein kinase, resulting in aberrant activation of the mitogen- activated protein MAP kinase signaling pathway
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.M.Sc.2013.Sa.P (Browse shelf(Opens below)) Not for loan 01010110062373000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.M.Sc.2013.Sa.P (Browse shelf(Opens below)) 62373.CD Not for loan 01020110062373000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology

Background: The activating point mutation v-Raf murine sarcoma viral oncogene homology B1 (BRAFV600E), is the most common and specific genetic alteration in papillary thyroid carcinoma (PTC) with a prevalence of 29-83% the mutation causes a change in amino acid at position 600 from valine to glutamic acid in the BRAF protein kinase, resulting in aberrant activation of the mitogen- activated protein MAP kinase signaling pathway

Issued also as CD

There are no comments on this title.

to post a comment.